These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 27612006)

  • 21. Peroxisome proliferator-activated receptor-α-mediated transcription of miR-199a2 attenuates endothelin-1 expression via hypoxia-inducible factor-1α.
    Li C; Mpollo MS; Gonsalves CS; Tahara SM; Malik P; Kalra VK
    J Biol Chem; 2014 Dec; 289(52):36031-47. PubMed ID: 25389292
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endothelin-1 decreases endothelial PPARγ signaling and impairs angiogenesis after chronic intrauterine pulmonary hypertension.
    Wolf D; Tseng N; Seedorf G; Roe G; Abman SH; Gien J
    Am J Physiol Lung Cell Mol Physiol; 2014 Feb; 306(4):L361-71. PubMed ID: 24337925
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The microRNA miR-199a-5p down-regulation switches on wound angiogenesis by derepressing the v-ets erythroblastosis virus E26 oncogene homolog 1-matrix metalloproteinase-1 pathway.
    Chan YC; Roy S; Huang Y; Khanna S; Sen CK
    J Biol Chem; 2012 Nov; 287(49):41032-43. PubMed ID: 23060436
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PPARγ Regulates Mitochondrial Structure and Function and Human Pulmonary Artery Smooth Muscle Cell Proliferation.
    Yeligar SM; Kang BY; Bijli KM; Kleinhenz JM; Murphy TC; Torres G; San Martin A; Sutliff RL; Hart CM
    Am J Respir Cell Mol Biol; 2018 May; 58(5):648-657. PubMed ID: 29182484
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA-27a Induces Mesangial Cell Injury by Targeting of PPARγ, and its In Vivo Knockdown Prevents Progression of Diabetic Nephropathy.
    Wu L; Wang Q; Guo F; Ma X; Ji H; Liu F; Zhao Y; Qin G
    Sci Rep; 2016 May; 6():26072. PubMed ID: 27184517
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pulmonary arterial hypertension is linked to insulin resistance and reversed by peroxisome proliferator-activated receptor-gamma activation.
    Hansmann G; Wagner RA; Schellong S; Perez VA; Urashima T; Wang L; Sheikh AY; Suen RS; Stewart DJ; Rabinovitch M
    Circulation; 2007 Mar; 115(10):1275-84. PubMed ID: 17339547
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tie2-mediated loss of peroxisome proliferator-activated receptor-gamma in mice causes PDGF receptor-beta-dependent pulmonary arterial muscularization.
    Guignabert C; Alvira CM; Alastalo TP; Sawada H; Hansmann G; Zhao M; Wang L; El-Bizri N; Rabinovitch M
    Am J Physiol Lung Cell Mol Physiol; 2009 Dec; 297(6):L1082-90. PubMed ID: 19801450
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential healing after sirolimus, paclitaxel, and bare metal stent placement in combination with peroxisome proliferator-activator receptor gamma agonists: requirement for mTOR/Akt2 in PPARgamma activation.
    Finn AV; John M; Nakazawa G; Polavarapu R; Karmali V; Xu X; Cheng Q; Davis T; Raghunathan C; Acampado E; Ezell T; Lajoie S; Eppihimer M; Kolodgie FD; Virmani R; Gold HK
    Circ Res; 2009 Nov; 105(10):1003-12. PubMed ID: 19797172
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TSP1-CD47 signaling is upregulated in clinical pulmonary hypertension and contributes to pulmonary arterial vasculopathy and dysfunction.
    Rogers NM; Sharifi-Sanjani M; Yao M; Ghimire K; Bienes-Martinez R; Mutchler SM; Knupp HE; Baust J; Novelli EM; Ross M; St Croix C; Kutten JC; Czajka CA; Sembrat JC; Rojas M; Labrousse-Arias D; Bachman TN; Vanderpool RR; Zuckerbraun BS; Champion HC; Mora AL; Straub AC; Bilonick RA; Calzada MJ; Isenberg JS
    Cardiovasc Res; 2017 Jan; 113(1):15-29. PubMed ID: 27742621
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peroxisome proliferator-activated receptor gamma depletion stimulates Nox4 expression and human pulmonary artery smooth muscle cell proliferation.
    Bijli KM; Kleinhenz JM; Murphy TC; Kang BY; Adesina SE; Sutliff RL; Hart CM
    Free Radic Biol Med; 2015 Mar; 80():111-20. PubMed ID: 25557278
    [TBL] [Abstract][Full Text] [Related]  

  • 31. miR-27a promotes endothelial-mesenchymal transition in hypoxia-induced pulmonary arterial hypertension by suppressing BMP signaling.
    Liu T; Zou XZ; Huang N; Ge XY; Yao MZ; Liu H; Zhang Z; Hu CP
    Life Sci; 2019 Jun; 227():64-73. PubMed ID: 31004656
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNA-27a promotes podocyte injury via PPARγ-mediated β-catenin activation in diabetic nephropathy.
    Zhou Z; Wan J; Hou X; Geng J; Li X; Bai X
    Cell Death Dis; 2017 Mar; 8(3):e2658. PubMed ID: 28277542
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MiR-27a promotes insulin resistance and mediates glucose metabolism by targeting PPAR-γ-mediated PI3K/AKT signaling.
    Chen T; Zhang Y; Liu Y; Zhu D; Yu J; Li G; Sun Z; Wang W; Jiang H; Hong Z
    Aging (Albany NY); 2019 Sep; 11(18):7510-7524. PubMed ID: 31562809
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PPARγ ligands regulate NADPH oxidase, eNOS, and barrier function in the lung following chronic alcohol ingestion.
    Wagner MC; Yeligar SM; Brown LA; Michael Hart C
    Alcohol Clin Exp Res; 2012 Feb; 36(2):197-206. PubMed ID: 21762184
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endothelial nitric oxide synthase-enhancing G-protein coupled receptor antagonist inhibits pulmonary artery hypertension by endothelin-1-dependent and endothelin-1-independent pathways in a monocrotaline model.
    Liu CP; Dai ZK; Huang CH; Yeh JL; Wu BN; Wu JR; Chen IJ
    Kaohsiung J Med Sci; 2014 Jun; 30(6):267-78. PubMed ID: 24835346
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Altered expression of PPAR‑γ and TRPC in neonatal rats with persistent pulmonary hypertension.
    Du Y; Fu J; Yao L; Qiao L; Liu N; Xing Y; Xue X
    Mol Med Rep; 2017 Aug; 16(2):1117-1124. PubMed ID: 28627661
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peroxisome proliferator-activated receptor-γ ameliorates pulmonary arterial hypertension by inhibiting 5-hydroxytryptamine 2B receptor.
    Liu Y; Tian XY; Mao G; Fang X; Fung ML; Shyy JY; Huang Y; Wang N
    Hypertension; 2012 Dec; 60(6):1471-8. PubMed ID: 23108648
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vascular TSP1-CD47 signaling promotes sickle cell-associated arterial vasculopathy and pulmonary hypertension in mice.
    Novelli EM; Little-Ihrig L; Knupp HE; Rogers NM; Yao M; Baust JJ; Meijles D; St Croix CM; Ross MA; Pagano PJ; DeVallance ER; Miles G; Potoka KP; Isenberg JS; Gladwin MT
    Am J Physiol Lung Cell Mol Physiol; 2019 Jun; 316(6):L1150-L1164. PubMed ID: 30892078
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The microRNA-130/301 family controls vasoconstriction in pulmonary hypertension.
    Bertero T; Cottrill K; Krauszman A; Lu Y; Annis S; Hale A; Bhat B; Waxman AB; Chau BN; Kuebler WM; Chan SY
    J Biol Chem; 2015 Jan; 290(4):2069-85. PubMed ID: 25505270
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peroxisome proliferator-activated receptor gamma ligands stimulate endothelial nitric oxide production through distinct peroxisome proliferator-activated receptor gamma-dependent mechanisms.
    Polikandriotis JA; Mazzella LJ; Rupnow HL; Hart CM
    Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1810-6. PubMed ID: 16020752
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.